Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Ipilimumab

When and How to Receive This Medicine

Some general considerations to keep in mind during treatment with ipilimumab include the following:
 
  • This medication is given as an intravenous (IV) infusion, which is a slow injection into the vein. It is usually given every three weeks for up to four doses.
 
  • The injections are given by a healthcare provider in a healthcare setting.
 
  • Each ipilimumab dose will be given slowly over a 90-minute period.
 
  • Ipilimumab solution must be diluted prior to use. The solution should not be used if the medication is discolored, cloudy, or contains unknown particles.
 
  • For this drug to work properly, it must be used as prescribed. Ipilimumab will not work as well if you miss doses.
 

Storage Information

Ipilimumab should be refrigerated, but not frozen. The vials should be protected from light. This medication must be diluted prior to use. After it is diluted, it may be kept at room temperature for up to 24 hours. Any medicine left over in the vial must be discarded. It cannot be saved for another dose.
 
Make sure to keep this and all other medications out of the reach of children and pets.
 

Is There a Generic Version?

This medication is not available in generic form (see Generic Yervoy).
 

Who Makes Ipilimumab?

Ipilimumab is manufactured by Bristol-Myers Squibb Company.
 

Available Strengths

Ipilimumab comes in the following strengths:
 
  • Ipilimumab 5 mg per mL, 50-mg single-use vials
  • Ipilimumab 5 mg per mL, 200-mg single-use vials.
5 Easy Tips to Manage Visitors During Cancer Treatment

Ipilimumab Drug Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.